These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6626878

  • 21. Clinical trials of misonidazole in the United States.
    Wasserman TH, Stetz J, Phillips TL.
    Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
    [Abstract] [Full Text] [Related]

  • 22. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.
    Saunders ME, Dische S, Anderson P, Flockhart IR.
    Br J Cancer Suppl; 1978 Jun; 3():268-70. PubMed ID: 209808
    [Abstract] [Full Text] [Related]

  • 23. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.
    Bleehen NM.
    Cancer Clin Trials; 1980 Jun; 3(3):267-73. PubMed ID: 7002338
    [Abstract] [Full Text] [Related]

  • 24. Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
    Schwade JG, Makuch RW, Strong JM, Glatstein E.
    Cancer Treat Rep; 1982 Sep; 66(9):1743-50. PubMed ID: 6288238
    [Abstract] [Full Text] [Related]

  • 25. Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.
    Melgaard B, Hansen HS, Kamieniecka Z, Paulson OB, Pedersen AG, Tang X, Trojaborg W.
    Ann Neurol; 1982 Jul; 12(1):10-7. PubMed ID: 7114817
    [Abstract] [Full Text] [Related]

  • 26. Phenytoin-misonidazole: possible metabolic interaction.
    Gangji D, Schwade JG, Strong JM.
    Cancer Treat Rep; 1980 Jan; 64(1):155-6. PubMed ID: 7379050
    [Abstract] [Full Text] [Related]

  • 27. [Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
    Bamberg M, Tamulevicius P, Streffer C, Scherer E.
    Strahlentherapie; 1981 Aug; 157(8):524-36. PubMed ID: 7268822
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Microsomal enzyme inducers and hypervitaminosis A in rats.
    Tuchweber B, Garg BD, Salas M.
    Arch Pathol Lab Med; 1976 Feb; 100(2):100-5. PubMed ID: 946392
    [Abstract] [Full Text] [Related]

  • 35. Initial pharmacology and toxicology of intravenous desmethylmisonidazole.
    Coleman CN, Wasserman TH, Phillips TL, Strong JM, Urtasun RC, Schwade JG, Johnson RJ, Zagars G.
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(3-4):371-5. PubMed ID: 7107354
    [Abstract] [Full Text] [Related]

  • 36. Studies on the O-demethylation of misonidazole by rat liver microsomes.
    Shoemaker DD, McManus ME, Hoerauf R, Strong JM.
    Cancer Treat Rep; 1982 Jun; 66(6):1343-7. PubMed ID: 7083238
    [Abstract] [Full Text] [Related]

  • 37. Neurotoxicity of misonidazole in rats following intravenous administration.
    Graziano MJ, Henck JW, Meierhenry EF, Gough AW.
    Pharmacol Res; 1996 Jun; 33(6):307-18. PubMed ID: 8971952
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. New side effect of the hypoxic cell sensitizer, misonidazole.
    Partington J, Koziol D, Chapman D, Rabin H, Urtasun RC.
    Cancer Treat Rep; 1979 Jan; 63(1):123-5. PubMed ID: 217536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.